Conventionals: Not only cheaper than atypicals, but more effective? Carlat Reports

Conventionals: Not only cheaper than atypicals, but more effective?

The Carlat Psychiatry Report, Volume 5, Number 1, January 2007
https://www.thecarlatreport.com/newsletter-issue/tcprv5n1/

From The Carlat Psychiatry Report, January 2007, Antidepressant Round-up 2007

Issue Links: Learning Objectives | Editorial Information

Topics: Antipsychotics

The latest results from the CATIE trial indicate that treatment with Trilafon (perphenazine) is not only much cheaper than treatment with SGAs (second generation antipsychotics), but leads to superior overall quality of life for patients.

You can't view details of this content, please login or buy subscription here